Hydration Pharmaceuticals Co Ltd
ASX:HPC
Income Statement
Earnings Waterfall
Hydration Pharmaceuticals Co Ltd
Income Statement
Hydration Pharmaceuticals Co Ltd
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Revenue |
6
N/A
|
8
+30%
|
9
+14%
|
10
+13%
|
4
-58%
|
7
+52%
|
3
-51%
|
2
-52%
|
|
| Gross Profit | |||||||||
| Cost of Revenue |
(3)
|
(4)
|
(4)
|
(5)
|
(2)
|
(3)
|
(2)
|
(0)
|
|
| Gross Profit |
3
N/A
|
4
+42%
|
5
+19%
|
5
+7%
|
2
-62%
|
4
+89%
|
2
-55%
|
(0)
N/A
|
|
| Operating Income | |||||||||
| Operating Expenses |
(10)
|
(14)
|
(15)
|
(15)
|
(9)
|
(10)
|
(6)
|
(5)
|
|
| Selling, General & Administrative |
(10)
|
(14)
|
(15)
|
(15)
|
(9)
|
(10)
|
(6)
|
(3)
|
|
| Depreciation & Amortization |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
|
| Operating Income |
(7)
N/A
|
(10)
-41%
|
(11)
-11%
|
(10)
+8%
|
(7)
+30%
|
(6)
+11%
|
(4)
+31%
|
(3)
+20%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
(1)
|
(1)
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(9)
N/A
|
(11)
-23%
|
(11)
+3%
|
(10)
+7%
|
(7)
+27%
|
(7)
+3%
|
(6)
+19%
|
(4)
+31%
|
|
| Net Income | |||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(9)
|
(11)
|
(11)
|
(10)
|
(7)
|
(7)
|
(6)
|
(4)
|
|
| Net Income (Common) |
(9)
N/A
|
(11)
-23%
|
(11)
+3%
|
(10)
+7%
|
(8)
+18%
|
(8)
+5%
|
3
N/A
|
4
+63%
|
|
| EPS (Diluted) |
-0.06
N/A
|
-0.08
-33%
|
-0.06
+25%
|
-0.06
N/A
|
-0.04
+33%
|
-0.03
+25%
|
0
N/A
|
0.01
N/A
|
|